Skip to content

Clinical trials

Phase 3 Prostatic Neoplasms trials in Latvia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 3 Country / region: Latvia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20081
20092
20101
20112
20131
20141
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ipsen3
Amgen2
Active Biotech AB1
AstraZeneca1
Bayer1
GlaxoSmithKline1
Merck Sharp & Dohme LLC1
Millennium Pharmaceuticals, Inc.1
SOTIO a.s.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms12
Neoplasms2
Bone Diseases, Metabolic1
Breast Neoplasms1
Cataract1
Neoplasm Metastasis1
Osteoporosis1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.